Answers are grounded in this paper and cite their sources.
Demonstrates apoptosis in breast cancer cells using a PARP1-targeting small molecule, suggesting potential therapy.
Poly (ADP-ribose) polymerase-1 (PARP1) is a major member of the PARP superfamily that is involved in DNA damage signalling and other important cellular processes. Here we report the development of a small molecule targeting PARP1 based on the PROTAC strategy. In the MDA-MB-231 cell line, the representative compound 3 can induce significant PARP1 cleavage and programmed cell death.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: